JAN 18, 2020 9:25 AM PST

What's the deal with turmeric?

Have you fallen for the turmeric craze? That little orange root that yellows your fingers when you peel it has become very popular recently for its medicinal properties, particularly those relating to inflammation, metabolic syndrome, arthritis, liver disease, obesity, and neurodegenerative diseases. But new research wanted to consider the potential of turmeric from another angle: cancer.

In a comprehensive literature review of the studies conducted on turmeric over the last thirty years, researchers concluded that while turmeric may be effective for cancer treatment, it isn’t anywhere close to reaching clinical trials. The root is a cousin of ginger and is native to India and Southeast Asia.

The study was published recently in the journal Nutrients and considered how turmeric might influence certain cell signaling pathways that play a role in cancer's growth and development. They wanted to see how the polyphenol in turmeric called diferuloylmethane, or curcumin works in concurrence with certain cancers, specifically, breast cancer, lung cancer, cancers of the blood, and cancers of the digestive system.

According to Medical News Today, the researchers found that curcumin is capable of influencing “a wide range of molecules that play a role in cancer, including transcription factors, which are vital for DNA replication; growth factors; cytokines, which are important for cell signaling; and apoptotic proteins, which help control cell death.” These findings led them to conclude that curcumin has potential as an anticancer drug and it one of the most promising natural compounds discovered to date.

Turmeric has long been known for its medicinal properties. But can it fight cancer? Photo: Pixabay

Nevertheless, the authors warn that this conclusion is not without its shortcomings. "[C]urcumin is not immune from side effects, such as nausea, diarrhea, headache, and yellow stool,” they write. Additionally, curcumin administered orally results in the body quickly breaking the compound into metabolites, which will likely not target tumors. “Moreover, it showed poor bioavailability due to the fact of low absorption, rapid metabolism, and systemic elimination that limit its efficacy in disease treatment. Further studies and clinical trials in humans are needed to validate curcumin as an effective anticancer agent."

The team hopes that their findings will act to encourage future investigations for the anticancer properties of curcumin in humans.

Sources: Medical News Today, Nutrients

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
FEB 23, 2021
Cancer
Quantifying cancer survivors' stress during the early months of the pandemic
FEB 23, 2021
Quantifying cancer survivors' stress during the early months of the pandemic
Approximately one-third of cancer survivors were psychologically distressed during the early months of the pandemic due ...
MAR 01, 2021
Cancer
How can we better target cancer stem cells?
MAR 01, 2021
How can we better target cancer stem cells?
In an effort to address the high probability of relapse for elderly patients with acute myeloid leukemia, researchers fr ...
APR 03, 2021
Drug Discovery & Development
Why Are Some Cancer Therapeutics Ineffective?
APR 03, 2021
Why Are Some Cancer Therapeutics Ineffective?
Why don’t some cancer therapeutics not work in humans when they were successful in mice? The answer to this questi ...
APR 13, 2021
Cancer
New efforts to predict which patients will suffer from side effects from immunotherapy
APR 13, 2021
New efforts to predict which patients will suffer from side effects from immunotherapy
The findings from a study published in the Journal for ImmunoTherapy of Cancer give medical professionals a way to predi ...
MAY 05, 2021
Cancer
Developing Therapies to Combat Drug-Resistant Cell States
MAY 05, 2021
Developing Therapies to Combat Drug-Resistant Cell States
Drug resistant tumors present challenges in cancer treatment A significant challenge in the treatment of cancers is the ...
MAY 07, 2021
Cancer
Pandemic times haven't been fun for anyone, but they've been especially hard for cancer patients
MAY 07, 2021
Pandemic times haven't been fun for anyone, but they've been especially hard for cancer patients
The pandemic hit everyone hard on many levels; now, new research from UCSF published in Cancer reports that cancer patie ...
Loading Comments...